| Robert L Berk, MD | |
|
6 Earlin Ave Ste 290, Browns Mills, NJ 08015-1780 | |
| (609) 537-7200 | |
| (609) 896-3986 |
| Full Name | Robert L Berk |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 36 Years |
| Location | 6 Earlin Ave Ste 290, Browns Mills, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609970805 | NPI | - | NPPES |
| 0014846240005 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD045704L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Capital Health Medical Center - Hopewell | Pennington, NJ | Hospital |
| St Mary Medical Center | Langhorne, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Health Medical Group | 7618264532 | 364 |
| Capital Health Medical Group | 7618264532 | 364 |
News Archive
After criticizing California insurer Anthem for raising premiums 10 days ago, Obama administration officials are preparing for more, The Washington Post reports. "Health and Human Services Secretary Kathleen Sebelius has scheduled a late-morning news conference, at which she is to cite half a dozen examples," where insurers have sought big rate hikes for individual coverage.
Proteolix, Inc. today announced positive clinical data demonstrating that the company's lead product, carfilzomib, has single-agent activity and promotes durable responses in patients with relapsed and refractory multiple myeloma.
Celsion Corporation announced today that the consensus recommendations of the National Cancer Institute (NCI) Clinical Trials Planning Meeting (CTPM) for Hepatocellular Carcinoma have been released and published in the August 2010 issue of Journal of Clinical Oncology, the official publication of American Society of Clinical Oncology (ASCO). In addition to evaluating the current standard of care, the NCI panel also recommended Celsion's Phase III ThermoDox ® HEAT Study as a Priority Clinical Trial for HCC.
A multi-disciplinary team of researchers has developed a new diagnostic test that can change the medical landscape by making it possible for patients to quickly determine if they are infected with an illness, using a simple paper test sensitive enough to detect markers of various illnesses using minute amounts of blood, sweat, or other biological material.
› Verified 2 days ago
| Entity Name | Capital Health Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437516887 PECOS PAC ID: 7618264532 Enrollment ID: O20161007001348 |
News Archive
After criticizing California insurer Anthem for raising premiums 10 days ago, Obama administration officials are preparing for more, The Washington Post reports. "Health and Human Services Secretary Kathleen Sebelius has scheduled a late-morning news conference, at which she is to cite half a dozen examples," where insurers have sought big rate hikes for individual coverage.
Proteolix, Inc. today announced positive clinical data demonstrating that the company's lead product, carfilzomib, has single-agent activity and promotes durable responses in patients with relapsed and refractory multiple myeloma.
Celsion Corporation announced today that the consensus recommendations of the National Cancer Institute (NCI) Clinical Trials Planning Meeting (CTPM) for Hepatocellular Carcinoma have been released and published in the August 2010 issue of Journal of Clinical Oncology, the official publication of American Society of Clinical Oncology (ASCO). In addition to evaluating the current standard of care, the NCI panel also recommended Celsion's Phase III ThermoDox ® HEAT Study as a Priority Clinical Trial for HCC.
A multi-disciplinary team of researchers has developed a new diagnostic test that can change the medical landscape by making it possible for patients to quickly determine if they are infected with an illness, using a simple paper test sensitive enough to detect markers of various illnesses using minute amounts of blood, sweat, or other biological material.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert L Berk, MD 540 Woodbourne Rd, Suite 1, Langhorne, PA 19047-1856 Ph: (215) 750-6611 | Robert L Berk, MD 6 Earlin Ave Ste 290, Browns Mills, NJ 08015-1780 Ph: (609) 537-7200 |
News Archive
After criticizing California insurer Anthem for raising premiums 10 days ago, Obama administration officials are preparing for more, The Washington Post reports. "Health and Human Services Secretary Kathleen Sebelius has scheduled a late-morning news conference, at which she is to cite half a dozen examples," where insurers have sought big rate hikes for individual coverage.
Proteolix, Inc. today announced positive clinical data demonstrating that the company's lead product, carfilzomib, has single-agent activity and promotes durable responses in patients with relapsed and refractory multiple myeloma.
Celsion Corporation announced today that the consensus recommendations of the National Cancer Institute (NCI) Clinical Trials Planning Meeting (CTPM) for Hepatocellular Carcinoma have been released and published in the August 2010 issue of Journal of Clinical Oncology, the official publication of American Society of Clinical Oncology (ASCO). In addition to evaluating the current standard of care, the NCI panel also recommended Celsion's Phase III ThermoDox ® HEAT Study as a Priority Clinical Trial for HCC.
A multi-disciplinary team of researchers has developed a new diagnostic test that can change the medical landscape by making it possible for patients to quickly determine if they are infected with an illness, using a simple paper test sensitive enough to detect markers of various illnesses using minute amounts of blood, sweat, or other biological material.
› Verified 2 days ago
Neil D Bluebond, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6 Earlin Ave, Ste 290, Browns Mills, NJ 08015 Phone: 609-537-7200 | |
Mark Kuhn, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6 Earlin Ave Ste 290, Browns Mills, NJ 08015 Phone: 609-537-7200 Fax: 609-896-3986 | |
Amy L. Harvey O'keeffe, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6 Earlin Ave Ste 290, Browns Mills, NJ 08015 Phone: 609-537-7200 Fax: 609-896-3986 |